Cargando…
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review
Inflammatory bowel disease (IBD) is a general term used to describe a group of chronic inflammatory conditions of the gastrointestinal tract of unknown etiology, including two primary forms: Crohn’s disease (CD) and ulcerative colitis (UC). The endocannabinoid system (ECS) plays an important role in...
Autores principales: | Hryhorowicz, Szymon, Kaczmarek-Ryś, Marta, Zielińska, Aleksandra, Scott, Rodney J., Słomski, Ryszard, Pławski, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727741/ https://www.ncbi.nlm.nih.gov/pubmed/35003109 http://dx.doi.org/10.3389/fimmu.2021.790803 |
Ejemplares similares
-
Colorectal carcinoma in the course of inflammatory bowel diseases
por: Hnatyszyn, Andrzej, et al.
Publicado: (2019) -
Pleiotropic Effects of Vitamin D in Patients with Inflammatory Bowel Diseases
por: Szymczak-Tomczak, Aleksandra, et al.
Publicado: (2022) -
Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities
por: Hryhorowicz, Szymon, et al.
Publicado: (2019) -
CCND1 gene polymorphic variants in patients with differentiated thyroid carcinoma
por: HRYHOROWICZ, SZYMON, et al.
Publicado: (2015) -
RET gene mutations spectrum in patients with medullary thyroid carcinoma (MTC) from Great Poland region
por: Kaczmarek-Ryś, Marta, et al.
Publicado: (2015)